Carbogen Inhalation Therapy

Carbogen inhalation therapy is considered experimental and investigational and therefore not covered for treatment of bladder cancer, central retinal artery occlusion, cervical cancer, or head and neck cancers (e.g., laryngeal, lip, mucosal melanoma, nasopharyngeal, oral cavity, paranasal sinuses, salivary gland). Coverage would require established effectiveness demonstrated in peer‑reviewed medical literature (the listed indications are not all‑inclusive).

"None specified — this Clinical Policy Bulletin does not list any covered indications for carbogen inhalation therapy. (The policy instead lists specific indications for which carbogen inhalation th..."

Sign up to see full coverage criteria, indications, and limitations.